[Federal Register: July 28, 2004 (Volume 69, Number 144)]
[Notices]               
[Page 45070]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28jy04-93]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

 
National Institutes of Health National Institute of Neurological 
Disorders and Stroke; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel High Throughput Molecular 
Screening Assay Development.
    Date: August 5-6, 2004.
    Time: 5 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Willard Hotel, 1401 Pennsylvania Avenue, Washington, 
DC 20004.
    Contact Person: W. Ernest Lyons, PhD, Scientific Review 
Administrator, Scientific Review Branch, NINDS/NIH/DHHS, 
Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, 
Bethesda, MD 20892-9529, 301-496-4056.


(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders, 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)
    Dated: July 21, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-17131 Filed 7-27-04; 8:45 am]

BILLING CODE 4140-01-M